ADVANCES IN PHARMACOGENETICSVESELL ES.1973; PROGR. MED. GENET.; U.S.A.; DA. 1973; VOL. 9; PP. 291-367; BIBL. 12P.1/2Serial Issue

PHARMACOGENETICSVESELL ES.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 4; PP. 445-450; BIBL. 62 REF.Article

GENETIC FACTORS IN THE RESPONSE TO ORAL ANTICOAGULANT DRUGS = FACTEURS GENETIQUES DE LA REPONSE AUX MEDICAMENTS ORAUX ANTICOAGULANTSO'REILLY RA.1973; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1973; NO 250; PP. 428-442; BIBL. 2P.; (C.R. IVE CONGR. INT. GENET. HUM.; PARIS; 1971)Conference Paper

PHARMACOGENETICS OF DRUGS USED IN ANAESTHESIA = PHARMACOGENETIQUE DES PRODUITS UTILISES EN ANESTHESIEKALOW W.1973; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1973; NO 250; PP. 415-427; BIBL. 3P.; (C.R. IVE CONGR. INT. GENET. HUM.; PARIS; 1971)Conference Paper

PHARMACOGENETICS OF HUMAN THIOPURINE METHYLTRANSFERASE: KIDNEY-ERYTHROCYTE CORRELATION AND IMMUNOTITRATION STUDIESWOODSON LC; DUNNETTE JH; WEINSHILBOUM RM et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 222; NO 1; PP. 174-181; BIBL. 22 REF.Article

POLYMORPHIC SULPHOXIDATION OF S-CARBOXYMETHYL-L-CYSTEINE IN MANWARING RH; MITCHELL SC; SHAH RR et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 19; PP. 3151-3154; BIBL. 11 REF.Article

DEBRISOQUINE HYDROXYLATION CAPACITY: PROBLEMS OF ASSESSMENT IN TWO POPULATIONSINABA T; OTTON SV; KALOW W et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 2; PP. 218-223; BIBL. 17 REF.Article

INTERINDIVIDUELLE UNTERSCHIEDE DER PHARMAKOKINETIK BEIM MENSCHEN. KLINISCHE BEDEUTUNG = LES DIFFERENCES INTERINDIVIDUELLES DE LA PHARMACOCINETIQUE CHEZ L'HOMME. LA VALEUR CLINIQUESJOEQVIST F.1972; MUENCH. MED. WSCHR.; DTSCH.; DA. 1972; VOL. 114; NO 38; PP. 1600-1608; ABS. ANGL.; BIBL. 1P.Serial Issue

A UNIQUE PHARMACOGENETIC EXPRESSION OF THE N-ACETYLATION POLYMORPHISM IN THE INBRED HAMSTERHEIN DW; OMICHINSKI JG; BREWER JA et al.1982; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1982; VOL. 220; NO 1; PP. 8-15; BIBL. 40 REF.Article

PHARMACOGENETICSPROPPING P.1978; REV. PHYSIOL. BIOCHEM. PHARMACOL.; DEU; DA. 1978; VOL. 83; PP. 123-173; BIBL. 7 P.Article

THE HOST REACTION TO TOXIC AGENTS.RENNERT OM.1976; ANN. CLIN. LAB. SCI.; U.S.A.; DA. 1976; VOL. 6; NO 4; PP. 300-305; BIBL. 22 REF.Article

GENOTYPE-DEPENDENT ELECTROENCEPHALOGRAPHIC, BEHAVIORAL AND ANALGESIC CORRELATES OF MORPHINE: AN ANALYSIS IN NORMAL MICE AND IN MICE WITH SEPTAL LESIONSOLIVERIO A.1975; BRAIN RES.; NETHERL.; DA. 1975; VOL. 83; NO 1; PP. 135-141; BIBL. 17REF.Article

RELATIONSHIP BETWEEN SUXAMETHONIUM APNOCA, SERUM CHOLINESTERASE ACTIVITY AND INHIBITOR NUMBERSKING J; GRIFFIN D.1974; BRIT. J. ANAESTH.; G.B.; DA. 1974; VOL. 46; NO 12; PP. 908-911; BIBL. 16REF.Article

ACTIVATION AND INACTIVATION OF CHEMICAL CARCINOGENS AND MUTAGENS IN THE MAMMALMAGEE PN.1974; ESSAYS IN BIOCHEM.; G.B.; DA. 1974; VOL. 10; PP. 105-136; BIBL. 9 P. 1/2Article

GENETIC AND ENVIRONMENTAL FACTORS AFFECTING DRUG RESPONSE IN MAN = FACTEURS GENETIQUES ET ENVIRONNANTS AFFECTANT LA REPONSE AUX MEDICAMENTS CHEZ L'HOMMEVESELL ES.1972; FEDER. PROC.; U.S.A.; DA. 1972; VOL. 31; NO 4; PP. 1253-1269; BIBL. 59REF.Serial Issue

ANTAGONISM OF SUCCINYLCHOLINE PARALYSIS IN A PATIENT WITH ATYPICAL PSEUDOCHOLINESTERASE = ANTAGONISME DE LA PARALYSIE PAR LA SUCCINYLCHOLINE CHEZ UN MALADE AVEC UNE PSEUDOCHOLINESTERASE ATYPIQUEMILLER RD; STEVENS WC.1972; ANESTHESIOLOGY; U.S.A.; DA. 1972; VOL. 36; NO 5; PP. 511-513; BIBL. 5REF.Serial Issue

PHARMAKOGENETIK: RUECK-UND AUSBLICK = PHARMACOGENETIQUE: ETUDE RETROSPECTIVE ET PROSPECTIVESZORADY I.sdPROTECT. VITAL; ALLEM.; DA. 197; VOL. 17; NO 4-5; PP. 168-171; BIBL. 11REF.Serial Issue

PHENOTYPING OF CYTOCHROMES P-450 IN HUMAN TISSUES WITH MONOCLONAL ANTIBODIESFUJINO T; SANG SHIN PARK; WEST D et al.1982; PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. BIOLOGICAL SCIENCES; ISSN 0273-1134; USA; DA. 1982; VOL. 79; NO 12; PP. 3682-3686; BIBL. 40 REF.Article

SPARTEINE METABOLISM IN CANADIAN CAUCASIANSVINKS A; INABA T; OTTON SV et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 1; PP. 23-29; BIBL. 25 REF.Article

DETERMINATION OF THE ACETYLATOR PHENOTYPE IN A NOTHERN NIGERIAN POPULATIONFAWCETT IW; GAMMON PT.1975; TUBERCULE; G.B.; DA. 1975; VOL. 56; NO 3; PP. 199-201; ABS. FR. ALLEM. ESP.; BIBL. 11 REF.Article

SUXAMETHONIUM SENSITIVITY AND SEGREGATION OF HUMAN SERUM CHOLINESTERASE VARIANTS AT LOCUS (CH.) AMONG TWELVE BRITISH FAMILIESDAS PK.1975; HUM. HERED.; SWITZ.; DA. 1975; VOL. 25; NO 6; PP. 461-471; BIBL. 20 REF.Article

A FILTER PAPER METHOD FOR DETERMINING ISONIAZID ACETYLATOR PHENOTYPE = UNE METHODE SUR PAPIER FILTRE POUR METTRE EN EVIDENCE LE PHENOTYPE ACETYLATEUR DE L'ISONIAZIDEWEBER WW; BRENNER W.1974; AMER. J. HUM. GENET.; U.S.A.; DA. 1974; VOL. 26; NO 4; PP. 467-473; BIBL. 1P.Article

STRAIN DIFFERENCES IN THE ANALGESIC RESPONSE TO MORPHINE AS MEASURED ON THE HOT PLATE = DIFFERENCES ENTRE LES SOUCHES DANS LA REPONSE ANALGESIQUE A LA MORPHINE MESUREE SUR LA PLAQUE CHAUFFANTEGEBHART GF; MITCHELL CL.1973; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1973; VOL. 201; NO 1; PP. 128-140; BIBL. 28REF.Serial Issue

CORRELATION BETWEEN INH INACTIVATION AND THERAPEUTIC RESULT IN SKIN TUBERCULOSIS (LUPUS VULGARIS) = CORRELATION ENTRE L'INACTIVATION DE L'ISONIAZIDE (INH) ET LE RESULTAT THERAPEUTIQUE DANS LA TUBERCULOSE CUTANEE (LUPUS VULGAIRE)FOERSTROEM L; MATTILA MJ; TIITINEN H et al.1972; ANN. CLIN. RES.; FINL.; DA. 1972; VOL. 4; NO 3; PP. 165-168; BIBL. 15 REF.Serial Issue

DRUG THERAPY: PHARMACOGENETICSVESELL ES.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 287; NO 18; PP. 904-909; BIBL. 28REF.Serial Issue